Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells

Biomaterials

Volumn 32, Issue 26, 2011, Pages 5994-6005

  Li, Hsin Yang ^a,c   Chien, Yueh ^a,c   Chen, Yi Jen ^a,c   Chen, Szu Fu ^a,b   Chang, Yuh Lih ^a   Chiang, Chih Hung ^a,c   Jeng, Shaw Yeu ^a,c   Chang, Chia Ming ^a,c   Wang, Mong Lien ^a   Chen, Liang Kung ^a,c   Hung, Shuen Iu ^a   Huo, Teh Ia ^a,c   Lee, Shou Dong ^a   Chiou, Shih Hwa ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute hepatic failure; Hepatocytes; Induced pluripotent stem cell; Reactive oxygen species

Indexed keywords

ACUTE HEPATIC FAILURE; ANTIOXIDANT ENZYME; BIOLOGICAL FUNCTIONS; HEPATIC DIFFERENTIATION; HEPATIC REGENERATION; HEPATOCYTES; HOECHST; IN-VITRO; IN-VIVO; MOUSE EMBRYONIC FIBROBLASTS; PLURIPOTENT STEM CELLS; PRE-TREATMENT; QUANTITATIVE RT-PCR; REACTIVE OXYGEN SPECIES; SOMATIC CELLS; STRESS-INDUCED DAMAGE; THIOACETAMIDE; TUMOR FORMATION;

BIOINFORMATICS; CELL CULTURE; GENE EXPRESSION; GRAFTS; MAMMALS; TUMORS;

STEM CELLS;

ANTIOXIDANT; MYC PROTEIN; RADIOISOTOPE; THIOACETAMIDE;

ACUTE LIVER FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER FUNCTION; LIVER INJURY; LIVER NECROSIS; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCINTISCANNING; STEM CELL TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; DRUG-INDUCED LIVER INJURY; HEPATOCYTES; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIPOPROTEINS, LDL; LIVER FUNCTION TESTS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXB1 TRANSCRIPTION FACTORS;

MUS;

EID: 79959915591     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.009     Document Type: Article

References (45)

1. Tunon M.J., Alvarez M., Culebras J.M., Gonzalez-Gallego J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol 2009, 15(25):3086-3098.
2. Fiegel H.C., Kaufmann P.M., Bruns H., Kluth D., Horch R.E., Vacanti J.P., et al. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med 2008, 12(1):56-66.
3. Heo J., Factor V.M., Uren T., Takahama Y., Lee J.S., Major M., et al. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology 2006, 44(6):1478-1486.
4. Chinzei R., Tanaka Y., Shimizu-Saito K., Hara Y., Kakinuma S., Watanabe M., et al. Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology 2002, 36(1):22-29.
5. Fair J.H., Cairns B.A., Lapaglia M.A., Caballero M., Pleasant W.A., Hatada S., et al. Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro. Proc Natl Acad Sci U S A 2005, 102(8):2958-2963.
6. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872.
7. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451(7175):141-146.
8. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448(7151):313-317.
9. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318(5858):1917-1920.
10. Si-Tayeb K., Noto F.K., Nagaoka M., Li J., Battle M.A., Duris C., et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010, 51(1):297-305.
11. Sancho-Bru P., Roelandt P., Narain N., Pauwelyn K., Notelaers T., Shimizu T., et al. Directed differentiation of murine-induced pluripotent stem cells to functional hepatocyte-like cells. J Hepatol 2010, 54(1):98-107.
12. Rashid S.T., Corbineau S., Hannan N., Marciniak S.J., Miranda E., Alexander G., et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 2010, 120(9):3127-3136.
13. Pelengaris S., Khan M., Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002, 2(10):764-776.
14. Knoepfler P.S. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009, 27(5):1050-1056.
15. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008, 26(1):101-106.
16. Armstrong L., Tilgner K., Saretzki G., Atkinson S.P., Stojkovic M., Moreno R., et al. Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 2010, 28(4):661-673.
17. Saretzki G., Walter T., Atkinson S., Passos J.F., Bareth B., Keith W.N., et al. Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells. Stem Cells 2008, 26(2):455-464.
18. Saretzki G., Armstrong L., Leake A., Lako M., von Zglinicki T. Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells 2004, 22(6):962-971.
19. Okuyama H., Shimahara Y., Nakamura H., Araya S., Kawada N., Yamaoka Y., et al. Thioredoxin prevents thioacetamide-induced acute hepatitis. Comp Hepatol 2004, 1(3 Suppl.):S6.
20. Chen S.J., Chang C.M., Tsai S.K., Chang Y.L., Chou S.J., Huang S.S., et al. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev 2010, 19(11):1757-1767.
21. Kao C.L., Tai L.K., Chiou S.H., Chen Y.J., Lee K.H., Chou S.J., et al. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev 2010, 19(2):247-258.
22. Song Z., Cai J., Liu Y., Zhao D., Yong J., Duo S., et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009, 19(11):1233-1242.
23. Byrne J.A., Grieve D.J., Bendall J.K., Li J.M., Gove C., Lambeth J.D., et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 2003, 93(9):802-805.
24. Deng W.P., Yang W.K., Lai W.F., Liu R.S., Hwang J.J., Yang D.M., et al. Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir. Eur J Nucl Med Mol Imaging 2004, 31(1):99-109.
25. Rosenthal M.S., Cullom J., Hawkins W., Moore S.C., Tsui B.M., Yester M. Quantitative SPECT imaging: a review and recommendations by the Focus Committee of the Society of nuclear medicine Computer and Instrumentation Council. J Nucl Med 1995, 36(8):1489-1513.
26. Koehne G., Doubrovin M., Doubrovina E., Zanzonico P., Gallardo H.F., Ivanova A., et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol 2003, 21(4):405-413.
27. Wu C.W., Ping Y.H., Yen J.C., Chang C.Y., Wang S.F., Yeh C.L., et al. Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicol Appl Pharmacol 2007, 220(3):243-251.
28. Chiou S.H., Kao C.L., Lin H.T., Tseng W.S., Liu R.S., Chung C.F., et al. Monitoring the growth effect of xenotransplanted human medulloblastoma in an immunocompromised mouse model using in vitro and ex vivo green fluorescent protein imaging. Childs Nerv Syst 2006, 22(5):475-480.
29. Kerksick C., Willoughby D. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr 2005, 2:38-44.
30. Fulia F., Gitto E., Cuzzocrea S., Reiter R.J., Dugo L., Gitto P., et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001, 31(4):343-349.
31. Nakagawa M., Takizawa N., Narita M., Ichisaka T., Yamanaka S. Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A 2010, 107(32):14152-14157.
32. Espejel S., Roll G.R., McLaughlin K.J., Lee A.Y., Zhang J.Y., Laird D.J., et al. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest 2010, 120(9):3120-3126.
33. Kuo T.K., Hung S.P., Chuang C.H., Chen C.T., Shih Y.R., Fang S.C., et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008, 134(7):e1-e3. 2111-21, 21.
34. Ito K., Hirao A., Arai F., Takubo K., Matsuoka S., Miyamoto K., et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 2006, 12(4):446-451.
35. Diehn M., Cho R.W., Lobo N.A., Kalisky T., Dorie M.J., Kulp A.N., et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458(7239):780-783.
36. Jaeschke H., Gores G.J., Cederbaum A.I., Hinson J.A., Pessayre D., Lemasters J.J. Mechanisms of hepatotoxicity. Toxicol Sci 2002, 65(2):166-176.
37. Bruck R., Oren R., Shirin H., Aeed H., Papa M., Matas Z., et al. Hypothyroidism minimizes liver damage and improves survival in rats with thioacetamide induced fulminant hepatic failure. Hepatology 1998, 27(4):1013-1020.
38. Akbay A., Cinar K., Uzunalimoglu O., Eranil S., Yurdaydin C., Bozkaya H., et al. Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of rats. Hum Exp Toxicol 1999, 18(11):669-676.
39. Fong E.L., Chan C.K., Goodman S.B. Stem cell homing in musculoskeletal injury. Biomaterials 2011, 32(2):395-409.
40. Chen Y., Xiang L.X., Shao J.Z., Pan R.L., Wang Y.X., Dong X.J., et al. Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver. J Cell Mol Med 2010, 14(6B):1494-1508.
41. Ishii T., Yasuchika K., Machimoto T., Kamo N., Komori J., Konishi S., et al. Transplantation of embryonic stem cell-derived endodermal cells into mice with induced lethal liver damage. Stem Cells 2007, 25(12):3252-3260.
42. Su Z., Wu R., Tan Z., Li Y., Chen L., Luo J., et al. Early homing behavior of Stro-1- mesenchyme-like cells derived from human embryonic stem cells in an immunocompetent xenogeneic animal model. Biochem Biophys Res Commun 2010, 394(3):616-622.
43. Tsuji O., Miura K., Okada Y., Fujiyoshi K., Mukaino M., Nagoshi N., et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 2010, 107(28):12704-12709.
44. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322(5903):949-953.
45. Spence J.R., Mayhew C.N., Rankin S.A., Kuhar M.F., Vallance J.E., Tolle K., et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011, 470(7332):105-109.